div class=trans-pagebutton class=gotoPage data-page=1Page 1button div class=trans-imageimg data-url=documenta-docs-a-pressrelease9m2018pdf-biocon-launches-krabeva-a-biosimilar-bevacizumabhtmlpage=1 data-page=1 class=trans-thumb lazyload alt=Page 1: bioconcom › docs › PressRelease9m2018pdf · Biocon launches KRABEVA@ a biosimilar Bevacizumab in India for the treatment of patients with metastatic colorectal cancer and other loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader033fdocumentsusreader033viewer20220530185f1f2e976aed1745343e7803html5thumbnails1jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=2Page 2button div class=trans-imageimg data-url=documenta-docs-a-pressrelease9m2018pdf-biocon-launches-krabeva-a-biosimilar-bevacizumabhtmlpage=2 data-page=2 class=trans-thumb lazyload alt=Page 2: bioconcom › docs › PressRelease9m2018pdf · Biocon launches KRABEVA@ a biosimilar Bevacizumab in India for the treatment of patients with metastatic colorectal cancer and other loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII= data-src=https:reader033fdocumentsusreader033viewer20220530185f1f2e976aed1745343e7803html5thumbnails2jpg width=140 height=200 divdivdiv class=trans-pagebutton class=gotoPage data-page=3Page 3button div class=trans-imageimg data-url=documenta-docs-a-pressrelease9m2018pdf-biocon-launches-krabeva-a-biosimilar-bevacizumabhtmlpage=3 data-page=3 class=trans-thumb lazyload alt=Page 3: bioconcom › docs › PressRelease9m2018pdf · Biocon launches KRABEVA@ a biosimilar Bevacizumab in India for the treatment of patients with metastatic colorectal cancer and other loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAEAAAABCAQAAAC1HAwCAAAAC0lEQVR42mM8Uw8AAh0BTZud3BwAAAAASUVORK5CYII=...